← All indications
Gout
Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.
Subtype terms (1)
More specific conditions that are subtypes of Gout in the MeSH hierarchy.
- Arthritis, Gouty
22 drugs (15 approved, 7 experimental)
Drugs by status
Approved for this indication (11)
Phase 4 trials (17)
Phase 3 trials (19)
Phase 2 trials (27)
Phase 1 trials (15)
Other trials (25)
Organizations
Organization Involved with Phase 4 Indications (18)
- Regeneron
- Horizon Pharma
- Ardea Biosciences
- Ironwood Pharmaceuticals
- Amgen
- Horizon Therapeutics, LLC
- Menarini Group
- United States Air Force
- White River Junction VAMC
- Huazhong University of Science and Technology
- Keele University
- Rutgers University
- Medpace, Inc.
- Wilford Hall Ambulatory Surgical Center
- Department of Veteran Affairs
- Assistance Publique - Hôpitaux de Paris
- Medical Practice Prof D. Ivanov
- Dr. T. Bevzenko, Dr. O. Synyachenko, Dr. I. Golovach
Organization Involved with Phase 3 Indications (29)
- Takeda
- Astellas
- Novartis
- Hengrui Therapeutics, Inc.
- Mochida Pharmaceutical Company, Ltd.
- Selecta Biosciences, Inc.
- Fuji Yakuhin Co., Ltd.
- China Academy of Chinese Medical Sciences
- Guangxi Medical University
- Hacettepe University
- Henry Ford Health System
- Jilin University
- LanZhou University
- Qingdao University
- Shaanxi Provincial People's Hospital
- Shanxi Medical University
- Southend University Hospital Foundation NHS Trust
- University of East Anglia
- University of Essex
- Zhejiang University
- Jiao Tong University
- Luoyang Orthopedic-Traumatological Hospital
- AR Scientific, Inc.
- SK Chemicals
- National Institute for Health Research, United Kingdom
- Anglia Ruskin University
- Qingdao Shengbang Pharmaceutical Co., Ltd.
- Shantou University
- People's Liberation Army of China
Organization Involved with Phase 2 Indications (22)
- Pharmos
- BioCryst
- AstraZeneca
- Unimed Pharmaceuticals
- JW Pharmaceutical
- LG
- Nuon Therapeutics, Inc.
- R-Pharm
- Revive Therapeutics, Ltd.
- CymaBay Therapeutics, Inc.
- TWi Biotechnology, Inc.
- Duke University
- National Yang-Ming University
- University of Auckland
- Covance
- University of Otago
- University of Alabama, Birmingham
- Data Matrix, LTD
- Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
- Shanton Pharma Co., Ltd.
- Dyve Biosciences, Inc.
- Arthrosi Therapeutics
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (8)